BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

550 related articles for article (PubMed ID: 30660817)

  • 1. Should Sentinel Lymph Node Biopsy Be Performed for All T1b Melanomas in the New 8
    Egger ME; Stevenson M; Bhutiani N; Jordan AC; Scoggins CR; Philips P; Martin RC; McMasters KM
    J Am Coll Surg; 2019 Apr; 228(4):466-472. PubMed ID: 30660817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of the AJCC 7th edition change in T1 melanoma substaging on national utilization and outcomes of sentinel lymph node biopsy for thin melanoma.
    Hieken TJ; Grotz TE; Comfere NI; Inselman JW; Habermann EB
    Melanoma Res; 2015 Apr; 25(2):157-63. PubMed ID: 25647736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of sentinel lymph node positivity in thin melanoma using the National Cancer Database.
    Conic RRZ; Ko J; Damiani G; Funchain P; Knackstedt T; Vij A; Vidimos A; Gastman BR
    J Am Acad Dermatol; 2019 Feb; 80(2):441-447. PubMed ID: 30240775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A nomogram to predict node positivity in patients with thin melanomas helps inform shared patient decision making.
    Friedman C; Lyon M; Torphy RJ; Thieu D; Hosokawa P; Gonzalez R; Lewis KD; Medina TM; Rioth MJ; Robinson WA; Kounalakis N; McCarter MD; Gleisner AL
    J Surg Oncol; 2019 Dec; 120(7):1276-1283. PubMed ID: 31602665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sentinel node biopsy should be offered in thin melanoma with mitotic rate greater than one.
    Sekula-Gibbs SA; Shearer MA
    Dermatol Surg; 2011 Aug; 37(8):1080-8. PubMed ID: 21635622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use and Costs of Sentinel Lymph Node Biopsy in Non-Ulcerated T1b Melanoma: Analysis of a Population-Based Registry.
    Herb JN; Ollila DW; Stitzenberg KB; Meyers MO
    Ann Surg Oncol; 2021 Jul; 28(7):3470-3478. PubMed ID: 33900501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sentinel lymph node biopsy guideline concordance in melanoma: Analysis of the National Cancer Database.
    Narang J; Hue JJ; Bingmer K; Hardacre JM; Winter JM; Ocuin LM; Ammori JB; Mangla A; Bordeaux J; Rothermel LD
    J Surg Oncol; 2021 Sep; 124(4):669-678. PubMed ID: 34109633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sentinel lymph node biopsy in patients with thin melanomas: Frequency and predictors of metastasis based on analysis of two large international cohorts.
    Isaksson K; Nielsen K; Mikiver R; Nieweg OE; Scolyer RA; Thompson JF; Ingvar C
    J Surg Oncol; 2018 Sep; 118(4):599-605. PubMed ID: 30196533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of sociodemographic characteristics with utilization of sentinel lymph node biopsy for American Joint Committee on Cancer 8th edition T1b cutaneous melanoma.
    Zheng DX; Ahmed FA; Levoska MA; Tripathi R; Mulligan KM; Cwalina TB; Bordeaux JS; Ruiz ES; Rothermel LD; Hoehn RS; Scott JF
    Arch Dermatol Res; 2023 Nov; 315(9):2697-2701. PubMed ID: 37249586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is it Necessary to Perform Sentinel Lymph Node Biopsy in Thin Melanoma? A Retrospective Single Center Analysis.
    Kocsis A; Karsko L; Kurgyis Z; Besenyi Z; Pavics L; Dosa-Racz E; Kis E; Baltas E; Ocsai H; Varga E; Bende B; Varga A; Mohos G; Korom I; Varga J; Kemeny L; Nemeth IB; Olah J
    Pathol Oncol Res; 2020 Jul; 26(3):1861-1868. PubMed ID: 31792874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hospital-Based Study of Compliance with NCCN Guidelines and Predictive Factors of Sentinel Lymph Node Biopsy in the Setting of Thin Melanoma Using the National Cancer Database.
    Hayek SA; Munoz A; Dove JT; Hunsinger M; Arora T; Wild J; Shabahang M; Blansfield J
    Am Surg; 2018 May; 84(5):672-679. PubMed ID: 29966567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suboptimal Compliance With National Comprehensive Cancer Network Melanoma Guidelines: Who Is at Risk?
    Blakely AM; Comissiong DS; Vezeridis MP; Miner TJ
    Am J Clin Oncol; 2018 Aug; 41(8):754-759. PubMed ID: 28121641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of Sentinel Lymph Node Metastasis in Patients with Thin Melanoma: An International Multi-institutional Collaboration.
    Walker RJB; Look Hong NJ; Moncrieff M; van Akkooi ACJ; Jost E; Nessim C; van Houdt WJ; Stahlie EHA; Seo C; Quan ML; McKinnon JG; Wright FC; Mavros MN
    Ann Surg Oncol; 2022 Oct; 29(11):7010-7017. PubMed ID: 35676603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cervical sentinel lymph node biopsy for melanomas of the head and neck and upper thorax.
    Wagner JD; Park HM; Coleman JJ; Love C; Hayes JT
    Arch Otolaryngol Head Neck Surg; 2000 Mar; 126(3):313-21. PubMed ID: 10722003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utility of a Model for Predicting the Risk of Sentinel Lymph Node Metastasis in Patients With Cutaneous Melanoma.
    Marchetti MA; Dusza SW; Bartlett EK
    JAMA Dermatol; 2022 Jun; 158(6):680-683. PubMed ID: 35475908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Practice Patterns and Prognostic Value of Sentinel Lymph Node Biopsy for Thick Melanoma: A National Cancer Database Study.
    Song Y; Azari FS; Metzger DA; Fraker DL; Karakousis GC
    Ann Surg Oncol; 2019 Dec; 26(13):4651-4662. PubMed ID: 31485823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinico-pathological features of patients with melanoma and positive sentinel lymph node biopsy: a single institution experience.
    Homolak D; Šitum M; Čupić H
    Acta Dermatovenerol Croat; 2015; 23(2):122-9. PubMed ID: 26228823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathologic predictors of sentinel lymph node metastasis in thin melanoma.
    Han D; Zager JS; Shyr Y; Chen H; Berry LD; Iyengar S; Djulbegovic M; Weber JL; Marzban SS; Sondak VK; Messina JL; Vetto JT; White RL; Pockaj B; Mozzillo N; Charney KJ; Avisar E; Krouse R; Kashani-Sabet M; Leong SP
    J Clin Oncol; 2013 Dec; 31(35):4387-93. PubMed ID: 24190111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association Between Patient Age and Lymph Node Positivity in Thin Melanoma.
    Sinnamon AJ; Neuwirth MG; Yalamanchi P; Gimotty P; Elder DE; Xu X; Kelz RR; Roses RE; Chu EY; Ming ME; Fraker DL; Karakousis GC
    JAMA Dermatol; 2017 Sep; 153(9):866-873. PubMed ID: 28724122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of Anatomic Locations of T1b Melanomas and Patient Age on Outcomes.
    Huang MY; Chen A; Quarshie C; Masson R; Barajas G; Kim G; DeClerck B; Swanson MS; In GK; Kokot N; Pickering TA; Hu JC
    J Drugs Dermatol; 2024 May; 23(5):306-310. PubMed ID: 38709694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.